Abstract
(276) An open-label, Multicenter Study of the Safety, Pharmacokinetics, and Effectiveness of Buprenorphine Transdermal System (BTDS) in Children from 7 to 16 years of age, Inclusive, who Required Continuous Opioid Analgesia for Moderate to Severe Pain
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
